Agilent Technologies, Inc. (A)
NYSE: A · Real-Time Price · USD
136.87
+6.56 (5.03%)
Nov 1, 2024, 4:00 PM EDT - Market closed
Agilent Technologies Market Cap
Agilent Technologies has a market cap or net worth of $39.33 billion as of November 1, 2024. Its market cap has increased by 22.74% in one year.
Market Cap
39.33B
Enterprise Value
40.66B
1-Year Change
22.74%
Ranking
Category
Stock Price
$136.87
Market Cap Chart
Since November 18, 1999, Agilent Technologies's market cap has increased from $19.58B to $39.33B, an increase of 100.85%. That is a compound annual growth rate of 2.83%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 1, 2024 | 39.33B | -3.46% |
Dec 29, 2023 | 40.74B | -8.06% |
Dec 30, 2022 | 44.31B | -8.10% |
Dec 31, 2021 | 48.21B | 32.61% |
Dec 31, 2020 | 36.36B | 37.40% |
Dec 31, 2019 | 26.46B | 23.15% |
Dec 31, 2018 | 21.49B | -0.67% |
Dec 29, 2017 | 21.63B | 47.57% |
Dec 30, 2016 | 14.66B | 5.55% |
Dec 31, 2015 | 13.89B | 1.17% |
Dec 31, 2014 | 13.73B | -27.66% |
Dec 31, 2013 | 18.98B | 33.22% |
Dec 31, 2012 | 14.24B | 17.14% |
Dec 30, 2011 | 12.16B | -15.56% |
Dec 31, 2010 | 14.40B | 32.87% |
Dec 31, 2009 | 10.84B | 97.00% |
Dec 31, 2008 | 5.50B | -59.69% |
Dec 31, 2007 | 13.65B | -3.81% |
Dec 29, 2006 | 14.19B | -13.76% |
Dec 30, 2005 | 16.45B | 40.21% |
Dec 31, 2004 | 11.73B | -15.73% |
Dec 31, 2003 | 13.92B | 65.99% |
Dec 31, 2002 | 8.39B | -35.63% |
Dec 31, 2001 | 13.03B | -47.46% |
Dec 29, 2000 | 24.80B | -27.91% |
View and export this data all the way back to 1999.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Takeda Pharmaceutical | 44.34B |
Haleon | 43.40B |
Edwards Lifesciences | 40.37B |
GE HealthCare Technologies | 39.91B |
IQVIA Holdings | 37.52B |
ResMed | 35.59B |
argenx SE | 35.16B |
Alnylam Pharmaceuticals | 34.22B |